
Planting seeds of success: A new early-stage fund in Cancer ...
Debiopharm Innovation Fund, the Swiss biopharma’s strategic investing arm managing a $150 million fund, is looking to get involved earlier in the investment process with the launch of a new

CureVac claims advantage in BioNTech patent dispute
A court in Germany has suspended a trial discussing litigation brought against BioNTech and Pfizer by CureVac alleging patent infringement in connection with their mRNA-ba

Virgin Pulse eyes $3bn merger with HealthComp
Digital health and wellness company Virgin Pulse has said it plans to merge with HealthComp, a health benefits administrator, in a $3 billion transaction that would create

US channels $104m into antimicrobial resistance project
The US government has set aside a $104 million pot of funding for research into bacterial behaviour and antibiotic resistance, in the hope of speeding up diagnosis and ena

How to evaluate an omnichannel solution: A simple framework
In today’s complex communications landscape, the path of information from sender to recipient is not as straightforward as it once was.
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content

CRISPR-Based Therapy Analytical Development Summit
CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products.

4th Annual CRISPR 2.0 2023
CRISPR represents the next frontier in the cell and gene therapy landscape.

5th Annual Gene Therapy Analytical Development Summit 2023
Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the cornerstone of gene therapy development.

2nd Molecular Glue Drug Development Summit 2024
Molecular glue development continues to gain exponential momentum, with advances in screening tools, identification assays and structure-based design.

mRNA Assay Development Summit 2023
The mRNA Assay Development Summit is the first and only meeting to address the specific technical challenges of analytical, bioanalytical and potency assay development.